What Is Mounjaro (tirzepatide)?
You may have heard of the popular GLP-1 medication Semaglutide, which has been making a name for itself in the medical weight loss industry. Mounjaro is somewhat similar - but even more powerful.
​
In studies recently submitted to the FDA by Lilly, Mounjaro (which is already approved for treating Type 2 diabetes) was shown to lower body mass among users at its highest dose by up to 15%.
While Semaglutide targets the molecule glucagon-like peptide-1 (GLP-1) that's involved in insulin secretion, tirzepatide is the first to target two: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP).
Losing that excess weight begins here.
We know you live a busy life, so we've made the process easy.
​
1. Fill out the form below
2. We'll personally reach out to you to schedule your virtual appointment
3. If you qualify, your first dose arrives in a few days
